Skip to content
Datasets/rcc_iatlas_immotion150_2018

Renal Cell Carcinoma (IMmotion150 Clinical Trial, Nat Med. 2018) - iAtlas Harmonized

OpenMachine-extracted
Investigator-initiated cohort (harmonized in cBioPortal)Available from cBioPortal

A randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib in 263 patients with treatment-naive metastatic renal cell carcinoma. The reprocessing of raw sequencing data is coordinated by CRI iAtlas.

Can it answer your research question?

3 of 6 supported
  • Overall survival

    Not supported

    No usable overall-survival endpoint: vital status or follow-up time is missing; the cohort does carry progression-free interval.API

  • Progression or recurrence

    Supported

    A time to event is derivable: progression-free interval; progression_or_recurrence is informative for 100% of cases.API

  • Treatment response

    Supported

    CLINICAL_BENEFIT is populated for 94% of cases; criteria: Complete Response, Partial Response.API

  • Which drug was given

    Not measured

    This field was not among those probed for this repository.

  • Stage-adjusted modelling

    Supported

    CLINICAL_STAGE is informative for 100% of cases.API

  • Analysis by race or ethnicity

    Not measured

    This field was not among those probed for this repository.

Judged from the repository’s own field completeness (thresholds). “Not measured” means we have not probed that field for this record, not that the data lack it.

At a glance

Every percentage is the repository’s own record of what is filled in
CasesAPI
263
263 samples
Measurement types
2
Follow-upAPI
5.8 months
for 263 of 263 cases; progression-free interval
Treatment responseAPI
Recorded
Complete Response, Partial Response, Progressive Disease

SubjectCALC

Kidney

As filed by the repository

Renal Cell Carcinomakidney

Who is in the cohortAPI

The repository’s harmonized records carry no demographics for this dataset.

What was measured, and on how many

2 measurement types, 1 covering the whole cohort.

  • Mutation calls (panel, exome or genome)158 of 263 samples · 60%
  • RNA sequencing expression263 of 263 samples · 100%
Platform, files and data levels
AssayPlatformFilesLevels
Mutation calls (panel, exome or genome)API--processed matrix
RNA sequencing expressionAPI--processed matrix
How complete all 6 clinical fields are - 6 informative for at least 80% of cases

A field counts as informative only when it holds a real value. “Not reported” blocks an analysis just as a missing field does. Fields marked 1:n can hold several records per case, so they show the share of cases with any record.

Informative - a usable valuePresent but uninformative - “not reported” or “unknown”Absent - no value recorded

Outcome

  • Progression-Free StatusAPI100%
  • Progression-Free (Months)API100%

Treatment

  • Clinical BenefitAPI94%
  • ResponseAPI94%

Staging

  • Clinical StageAPI100%

Diagnosis

  • Oncotree CodeAPI100%

Access

OpenDownload without an account.API

Processed data download from the cBioPortal study page or its public REST API; no account required. Primary raw data remain wherever the original investigators deposited them.

Open components
harmonized mutation, copy-number, expression and clinical files
License
Per-study terms; cBioPortal asks that the original study be cited
Citation requirement
Cite the original publication, and cite cBioPortal if the portal's harmonized files were used.

What it is good for

Written and checked by a reviewer, not generated from metadata.

No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.

What it cannot tell you

Written by a reviewer against the source, not inferred from what is missing.

No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.

Who has used it

Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.

Analyzed the dataCALC
-
could not be measured for this dataset
Declared using it
-
named in a data availability statement
Cited the paper
1,010
attention to the publication, not reuse of the data
Against expectation
Not assessed
Reuse cannot be traced for this dataset
No accession is specific enough to search the literature for, so we cannot tell how often these data have been reused. That is a limit of the measurement, not a finding about the dataset. It is also a barrier in itself: a researcher cannot find prior work to build on.
Reuse assessment
  • Not assessed: this dataset has no accession specific enough for citation-based reuse tracing, so a shortfall cannot be measured.

Compared against rgi-huber-v2. See Methods for the model.

Original publication

Articles that analyzed the data

Not searchable. See the note above.

Community examples

Share your example

Analyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.

Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.

Start here

Starter code generated from this record’s own identifiers, then the access steps.

Get the data in code

cBioPortal: clinical data and the full study bundlepython
import requests, pandas as pd

STUDY = "rcc_iatlas_immotion150_2018"
base = "https://www.cbioportal.org/api"
clin = requests.get(f"{base}/studies/{STUDY}/clinical-data",
                    params={"clinicalDataType": "PATIENT", "projection": "SUMMARY"}, timeout=60).json()
patients = pd.DataFrame(clin).pivot_table(index="patientId", columns="clinicalAttributeId",
                                          values="value", aggfunc="first")
print(patients.shape)
profiles = requests.get(f"{base}/studies/{STUDY}/molecular-profiles", timeout=60).json()
print([p["molecularProfileId"] for p in profiles])
# Whole study as flat files: https://cbioportal-datahub.s3.amazonaws.com/rcc_iatlas_immotion150_2018.tar.gz
This page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/cbio-rcc-iatlas-immotion150-2018.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
    print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'

Access steps

  1. 1
    Open the study in cBioPortalFor people5 minutes

    Harmonized molecular and clinical files are open. Cite the original publication, and cite cBioPortal if the portal's harmonized files were used.

    https://www.cbioportal.org/study/summary?id=rcc_iatlas_immotion150_2018

    Generated from repository policy. Check the linked policy before downloading.

  2. 2
    Download the whole study as a zipFor peopleminutes

    The datasets page carries the staging files used by the portal.

    https://www.cbioportal.org/datasets

    Generated from repository policy. Check the linked policy before downloading.

  3. 3
    Or pull the staging files with git-lfsFor people

    Study folders are named by study id under public/.

    git clone https://github.com/cBioPortal/datahub.git && cd datahub
    git -c lfs.fetchexclude="" lfs pull -I public/rcc_iatlas_immotion150_2018
    https://github.com/cBioPortal/datahub

    Generated from repository policy. Check the linked policy before downloading.

  4. 4
    Read the study straight from the REST APIFor agents

    No key is required; pace requests when sweeping many studies.

    curl -s 'https://www.cbioportal.org/api/studies/rcc_iatlas_immotion150_2018/clinical-data?clinicalDataType=PATIENT&projection=SUMMARY'
    https://docs.cbioportal.org/web-api-and-clients/

    Generated from repository policy. Check the linked policy before downloading.

Provenance

All of it, and more, is in this record’s JSON.

Identifiers

Versions and verification

Metadata retrieved
18 Sept 2026
Review status
Machine-extracted
Data generation funding
Funded data generation

Funding

Awards resolved through NIH RePORTER. Awards that paid to generate these data are listed apart from awards that paid to reuse them. Both are returns on NCI investment, but different ones.

Funded data generation

  • P50CA101942DF/HCC Kidney Cancer Project 2: Optimizing Anti-PD1 Based Therapy in High Risk and Metastatic RCCArlene H. Sharpe, WILLIAM G. KAELINFY2023-2026API
  • P30CA068485Survey and Biospecimen Shared ResourceQIUYIN CAI, Eric P SkaarFY2025API
  • P30CA014599Integrated Small Animal Imaging Research ResourceCHIEN-MIN KAO, Scott A. OakesFY2025-2026API
  • P30CA008748Antitumor AssessmentElisa de Stanchina, FRANCESCA M GANYFY2025-2026API

For softwarerecord JSON